Trial · NCT02363452
Reverse Transcriptase Inhibitors in AGS
NCT02363452, Phase 2, Completed, Assistance Publique - Hôpitaux de Paris
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Reverse Transcriptase Inhibitors in AGS. Trials, record NCT02363452. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02363452
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Reverse Transcriptase Inhibitors in AGS
- NCT number
- NCT02363452
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 11 participants, actual
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Conditions
- Aicardi-Goutières Syndrome (AGS)
- Interventions
- Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir
- First posted
- 2015-02-16
- Last updated
- 2025-09-05
Source ClinicalTrials.gov
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Interferon signature | Before and after 12 months of treatment | Interferon Score |
| Secondary | Interferon signature | Month 18 | Interferon Score |
| Secondary | Adverse Events | Baseline until Month 18 | |
| Secondary | Interferon Activity Level in cerebrospinal fluid (UI/L) | Within the 12 month on treatment | |
| Secondary | Interferon Activity Level in blood (UI/L) | Within the 12 month on treatment | |
| Secondary | Interferon Activity Level in blood (UI/L) | month 18 | |
| Secondary | Interferon Protein in cerebrospinal fluid (Fg/mL) | within the 12 month on treatment | |
| Secondary | Interferon Protein in blood (FG/mL) | Within the 12 month on treatment | |
| Secondary | Interferon Protein in blood (Fg/mL) | Month 18 | |
| Secondary | Neurological assessment | Baseline | Scale for Evaluation of Movement Disorders Vineland Adaptive Behaviour Scales |
1 to 10 of 30Source ClinicalTrials.gov
See all 30 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02363452
GET https://conductscience.org/api/trials/v1/NCT02363452/registered?page=2